Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03902821 · ClinicalTrials.gov registry record
Reducing Overdose After Release From Incarceration
A clinical trial of Overdose, Drug, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- 65
- Enrollment target
- 1
- Study location
NCT03902821 is a study of Overdose, Drug that has completed, run by Oregon Health and Science University. The registered enrollment target is 65 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03902821, a study of Overdose, Drug, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- 65 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of the ROAR project is to evaluate an Oregon Department of Corrections (ODOC) pilot program that combines the use of extended-release naltrexone (XR-NTX) and Certified Recovery Mentors pre-release with linkage to community substance use disorder treatment to prevent fatal and non-fatal opioid overdoses among female adults released from prison.
Conditions Studied
Interventions
- OTHER XR-NTX and Certified Recovery Mentor
Study Locations (1)
Oregon
- Oregon Department of Corrections - Wilsonville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2019-06-17 |
| Est. Completion | 2023-11-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03902821
The ClinicalTrials.gov registry entry for NCT03902821 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Overdose, Drug appearing as the primary indexed condition, and to 1 intervention - of which XR-NTX and Certified Recovery Mentor is the first listed.
NCT03902821 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.
Frequently Asked Questions
What is clinical trial NCT03902821 about?
NCT03902821 is a clinical study titled "Reducing Overdose After Release From Incarceration". The primary objective of the ROAR project is to evaluate an Oregon Department of Corrections (ODOC) pilot program that combines the use of extended-release naltrexone (XR-NTX) and Certified Recovery Mentors pre-release with linkage to community substance use disorder treatment to prevent fatal and n...
What is the current status of trial NCT03902821?
This trial is currently completed. The enrollment target is 65 participants. The study started on 2019-06-17. Estimated completion is 2023-11-30.
What conditions does trial NCT03902821 study?
This clinical trial studies the following conditions: Overdose, Drug.
What interventions are being tested in trial NCT03902821?
The interventions under investigation include: XR-NTX and Certified Recovery Mentor (OTHER).
Who is sponsoring clinical trial NCT03902821?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03902821 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.